CD49d expression in chronic lymphocytic leukemia: a prognostic parameter and a therapeutic target

Author： Bulian Pietro   Gaidano Gianluca   Poeta Giovanni Del   Gattei Valter  

Publisher： Future Medicine

ISSN： 1479-6694

Source： Future Oncology, Vol.4, Iss.3, 2008-06, pp. : 355-358

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CD14+HLA-DRlow/ expression: A novel prognostic factor in chronic lymphocytic leukemia

By  

Oncology Letters, Vol. 9, Iss. 3, 2015-01 ,pp. : 1167-1172

Spandidos Publications

Access to resources Recommend Favorite

Prognostic and Predictive Indicators in Chronic Lymphocytic Leukemia(

By  

International Journal of Cancer Research and Prevention, Vol. , Iss. , 2017-01 ,pp. : 101-127

Nova Science Publishers, Inc.

Access to resources Recommend Favorite

Alemtuzumab in chronic lymphocytic leukemia

By James Danelle F   Kipps Thomas J  

Future Oncology, Vol. 3, Iss. 1, 2007-02 ,pp. : 29-42

Future Medicine

Access to resources Recommend Favorite

Chronic lymphocytic leukemia

By Andritsos Leslie   Khoury Hanna  

Current Treatment Options in Oncology, Vol. 3, Iss. 3, 2002-06 ,pp. : 225-231

Springer Publishing Company

Access to resources Recommend Favorite

ZAP-70 expression and proliferative activity in chronic lymphocytic leukemia

By Šoljić Violeta  

Leukemia and Lymphoma, Vol. 54, Iss. 6, 2013-06 ,pp. : 1171-1176

Informa Healthcare

Access to resources Recommend Favorite